NYSCC Lung Cancer Action Team Quarterly Member Meeting Series (2/4)

NYSCC Lung Cancer Action Team Quarterly Member Meeting Series (2/4)

Wednesday Sep 27, 2023

11:00AM - 12:30PM

The Lung Cancer Screening Action Team Presents: The Consortium in Action

The New York State Consortium’s Lung Cancer Screening Action Team (LCSAT) is made up of clinicians, researchers, educators, advocates, and organizations across the state who share the mission of decreasing the burden of lung cancer on New York State. The Action Team works to mobilize multi-level resources to increase lung cancer screening using guideline-driven, evidence-based strategies in an effort to save lives through early detection. 

Join us for a conversation that explores the status of lung cancer screening in New York State and examines current efforts and promising avenues to increase screening. 


  • Patricia Rivera, MD - Dr. Rivera is a Professor of Medicine in the Division of Pulmonary Diseases and Critical Care Medicine at University of Rochester Medical Center and the C. Jane Davis & C. Robert Davis Distinguished Professor in Pulmonary Medicine and the Chief of the Pulmonary and Critical Care Medicine Division, and the Associate Director of Diversity, Equity, and Inclusion at the Wilmot Cancer Institute. Her expertise includes screening, diagnosing, and staging lung cancer and managing treatment complications. For more than 20 years, Dr. Rivera has served and held leadership positions on National Pulmonary and Critical Care and Cancer societies, including the American Thoracic Society (ATS), The American College of Chest Physicians (CHEST), and the American Cancer Society National Lung Cancer Round Table. She currently serves as the President of ATS.

  • Andy Hyland, PhD - Dr. Hyland is the Chair of the Department of Health Behavior at Roswell Park Comprehensive Cancer Center as well as the Director of the New York Quitline.  Dr. Hyland’s primary research interests lie in evaluating the impact of policies aimed at reducing the morbidity and mortality associated with the use of tobacco products. Dr. Hyland also serves as Multiple Principle Investigator for a P01 that provides major support for the International Tobacco Control Policy Evaluation Project, which is conducting nationally representative surveys of tobacco use in 7 countries (including the US) to evaluate novel policies such as menthol bans in Canada and England, heated tobacco product policies in Japan and South Korea, and the reduced cigarette nicotine policy expected to be implemented in New Zealand.  Dr. Hyland’s research program is focused on providing an evidence base to inform interventions to reduce the disease burden caused by tobacco by as much and as quickly as possible. 

  • Nikia Clark, BS - Nikia is the Senior Community Outreach and Engagement Manager, and the staff lead for the Community Advisory Board (CAB) in the Office of Community Outreach and Engagement at Roswell Park Comprehensive Cancer Center. Nikia develops and nurtures strong partnerships with community organizations and key stakeholders who help champion and support the mission of health equity for cancer education, resources and cancer screenings to those underserved and most in need. Nikia manages a 12-member Community Advisory Board, a diverse group of community stakeholders that meet quarterly and help to strategically plan and advise the research and outreach efforts of the Office of Community Outreach and Engagement. She also holds the position of Program Manager for the ROCKstars (Research Oncology Community Knowledge) Advocate Program, where she leads the day-to-day operations as well as recruits and trains cancer survivors, community members and caregivers to become active research advocates.

  • Michael Davoli - Michael is the Senior Director of Government Relations New York at American Cancer Society Cancer Action Network, Inc. For more than 25 years, he has been a passionate advocate working on a variety of national, state and local policy campaigns across issues—from education to health care reform. Ensuring equitable access to cancer prevention and care has been a defining feature in 2022 and 2023. In the last year, Michael has built multiple coalitions of patient and provider groups, working to improve access to precision medicine through biomarker testing and expand access to cancer screening. Michael has mobilized stakeholders across the state and captured the attention of the media, resulting in bipartisan support for legislation to improve access to biomarker testing and cancer screening, help patients pay for prescription drugs, and curb tobacco use.

  • Mary Reid, BSN, MSPH, PhD - Dr. Reid is a cancer epidemiologist, Distinguished Professor of Oncology, Chief of Cancer Screening and Survivorship, and Director of Collaborative Research at Roswell Park Comprehensive Cancer Center (RPCCC). The lung cancer screening program at RPCCC has been in existence since 1998. The program has grown under her leadership to provide screening at three clinical sites, and most recently on a RPCCC owned mobile CT Unit. The mobile unit, EDDY (Early Detection Driven to You). Dr. Reid’s research is focused on studies to identify early genetic and transcriptomic changes indicative of progression to lung cancer. Finally, Dr. Reid is leading several efforts to improve the rates of lung cancer screening as the leader of the statewide NYS Department of Health Cancer Consortium Lung Cancer Screening Action Team (LCSAT), is a founding member of the NCCN Lung Cancer Screening Panel, and as the PI on a federally funded Lung Cancer Screening Registry, based at RPCCC.

Register Here

Previous Post
Next Post

Become a Member

The more we work together, the greater impact we will have towards preventing and controlling cancer in New York State.

join us now

This publication was supported by Cooperative Agreement Number, N5U58DP006309-04, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services, Health Research, Inc. or the NYS Department of Health.